M&G Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-165,739
Closed -$5.97M 452
2023
Q1
$5.97M Buy
+165,739
New +$6.01M 0.03% 238
2022
Q4
Sell
-20,897
Closed -$982 470
2022
Q3
$982 Hold
20,897
0.01% 322
2022
Q2
$1.5K Buy
20,897
+1,124
+6% +$82.2K 0.01% 302
2022
Q1
$1.6K Buy
+19,773
New +$1.67M ﹤0.01% 314
2020
Q3
Sell
-25,296
Closed -$1.47M 472
2020
Q2
$1.47M Sell
25,296
-1,603
-6% -$86.2K 0.02% 277
2020
Q1
$1.05M Sell
26,899
-54,510
-67% -$3.19M 0.01% 282
2019
Q4
$4.8M Buy
+81,409
New +$4.38M 0.04% 227

Other funds holding SYNH

M&G Investment Management's SYNH Position: Q2 2023 in Review

M&G Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 165,739 shares — an estimated $5.97M sold.

M&G Investment Management first reported a position in SYNH in Q4 2019 and held it in 7 quarters. The position peaked at $5.97M in Q1 2023. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • M&G Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • M&G Investment Management sold 165,739 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $5.97M.
  • M&G Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2019 and held it in 7 quarters.
  • M&G Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $5.97M in Q1 2023.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on M&G Investment Management's 13F filing for Q2 2023, filed 1 Aug 2023.